Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-03-26 @ 3:19 PM
NCT ID: NCT07363733
Eligibility Criteria: Inclusion Criteria: * Women aged 18 to 49 years (women of reproductive age); * Histologically confirmed diagnosis of vulvar lichen sclerosus; * Written informed consent to participate in the study. Exclusion Criteria: * Pregnancy or lactation; * Malignancy at the time of treatment or during any period of follow-up; * Postmenopausal status; * Severe decompensated somatic disease; * Sexually transmitted infections, including hepatitis B, hepatitis C, and syphilis; * Presence of a cardiac pacemaker or metal-containing intrauterine device (IUD); * History of treatment with other high-energy-based modalities within the last 6 months; * Use of topical corticosteroids within the last 3 months; * Immunosuppression, including immunodeficiency disorders (such as HIV/AIDS) or use of immunosuppressive medications; * Psychiatric disorders or communication difficulties that may interfere with study participation or compliance.
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Maximum Age: 49 Years
Study: NCT07363733
Study Brief:
Protocol Section: NCT07363733